Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future

被引:7
|
作者
Pouliquen, Daniel L. [1 ]
Troselj, Koraljka Gall [2 ]
Anto, Ruby John [3 ]
机构
[1] Nantes Univ, Univ Angers, Inserm, CNRS,CRCI2NA, CRCI2NA, F-49000 Angers, France
[2] Rudjer Boskovic Inst, Div Mol Med, Lab Epigen, Zagreb 10000, Croatia
[3] Inst Adv Virol, Mol Bioassay Lab, Thiruvananthapuram 695317, India
关键词
curcuminoids; curcumin; cancer; signaling pathways; metabolic reprogramming; chemosensitization; FACTOR-KAPPA-B; PROSTATE-CANCER CELLS; PENTOSE-PHOSPHATE PATHWAY; HUMAN COLORECTAL-CANCER; IN-VITRO; BREAST-CANCER; UP-REGULATION; CHEMOSENSITIZING EFFICACY; TUMOR MICROENVIRONMENT; INHIBITS PROLIFERATION;
D O I
10.3390/pharmaceutics15061612
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the diversity of inhibitory effects they have produced on a multitude of pathways involved in carcinogenesis and tumor progression have been provided. As this wealth of data was obtained in settings of various experimental and clinical data, this review first aimed at presenting a chronology of discoveries and an update on their complex in vivo effects. Secondly, there are many interesting questions linked to their pleiotropic effects. One of them, a growing research topic, relates to their ability to modulate metabolic reprogramming. This review will also cover the use of curcuminoids as chemosensitizing molecules that can be combined with several anticancer drugs to reverse the phenomenon of multidrug resistance. Finally, current investigations in these three complementary research fields raise several important questions that will be put among the prospects for the future research related to the importance of these molecules in cancer research.
引用
收藏
页数:31
相关论文
共 29 条
  • [1] Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
    Bojkova, Bianka
    Kubatka, Peter
    Qaradakhi, Tawar
    Zulli, Anthony
    Kajo, Karol
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [2] Recent advances in catalytic anticancer drugs: Mechanistic investigations and future prospects
    Tyagi, Kartikay
    Dixit, Tejal
    Venkatesh, V.
    INORGANICA CHIMICA ACTA, 2022, 533
  • [3] Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
    Guo, Zhi-Xun
    Ma, Jia-Li
    Zhang, Jin-Qiu
    Yan, Ling-Ling
    Zhou, Ying
    Mao, Xin-li
    Li, Shao-Wei
    Zhou, Xian-Bin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [4] Trans-platinum complexes as anticancer drugs: Recent developments and future prospects
    Radulovic, S
    Tesic, Z
    Manic, S
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (17) : 1611 - 1618
  • [5] Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
    Rangarajan, Parakalan
    Eng-Ang, Ling
    Dheen, S. Thameem
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (06) : 799 - 806
  • [6] Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
    van Rijt, Sabine H.
    Sadler, Peter J.
    DRUG DISCOVERY TODAY, 2009, 14 (23-24) : 1089 - 1097
  • [7] Effects of microbiota on anticancer drugs: Current knowledge and potential applications
    Huang, Jiayuan
    Liu, Wenting
    Kang, Wanying
    He, Yulong
    Yang, Ruifu
    Mou, Xiangyu
    Zhao, Wenjing
    EBIOMEDICINE, 2022, 83
  • [8] Anticancer Drugs: Potential and Actual Hazards of Occupational Effects.
    Sorsa, M.
    Meditsina Truda I Promyshlennaya Ekologiya, 1987, (04): : 8 - 11
  • [9] Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects
    Xiang, Shouyan
    Li, Yubei
    Khan, Shah Nawaz
    Zhang, Weixin
    Yuan, Gaoyang
    Cui, Jiahua
    PHARMACEUTICALS, 2025, 18 (03)
  • [10] Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs
    Mukhtar, Yusif M.
    Adu-Frimpong, Michael
    Xu, Ximing
    Yu, Jiangnan
    BIOSCIENCE REPORTS, 2018, 38